Filing Flows

Filing Flows › Strata Critical Medical (SRTA) › Q2 2026

Strata Critical Medical (SRTA) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 4, 2026

Strata Critical Medical (SRTA) reported revenue of $72.5M for the second quarter 2026 (Q2 2026), +61% from a year earlier and +8% from the quarter before. Operating margin was -7.5%, net loss $10.5M (14.5% of revenue).

Revenue$72.5M
Year over year+61%
Quarter over quarter+8%
Operating margin-7.5%
Net earnings−$10.5M

Strata Critical Medical, Q2 2026: revenue $72.5M (+61% year over year), operating margin -7.5%, net loss $10.5M, operating cash flow $5.7M. The chart follows the revenue to costs, profit and cash.

Q2 2026AmountQ/QY/Y
Revenue$72.5M+8%+61%
Operating profit−$5.4M——
Net earnings−$10.5M-588%—
Operating cash flow$5.7M+46%—
Free cash flow$2.9M——

What changed

Revenue was $72.5M in Q2 2026, up 61% year over year and up 8% from the previous quarter. Logistics was the largest line at 67% of revenue. Logistics added $3.1M year over year (up 7%), 11% of the total change.

Gross margin was 21.0%, up 1.0 points from Q2 2025. Operating costs exceeded revenue by $5.4M, an operating margin of -7.5%. Operating expenses grew 51% against revenue growth of 61%. The fastest-growing cost line was Other operating costs (+1762%). The quarter ended with a net loss of $10.5M, after a profit of $2.2M the previous quarter.

Operating cash flow was $5.7M. Non-cash charges added back $8.5M of depreciation and amortization and $3.7M of share-based compensation. Working capital and other items added $4.0M. After purchase of property and equipment, net of proceeds from disposal ($2.5M) and capitalized software development costs ($314K), free cash flow as the company reports it was $2.9M.

Questions

What was Strata Critical Medical's revenue in the second quarter 2026?

Strata Critical Medical (SRTA) reported revenue of $72.5M for the second quarter 2026 (Q2 2026), +61% from a year earlier and +8% from the quarter before.

Was Strata Critical Medical profitable in the second quarter 2026?

Operating loss was $5.4M (-7.5% of revenue) and net loss $10.5M.

Open the interactive Sankey →

Source: Strata Critical Medical 10-Q on SEC EDGAR.